USPTO serial 79347151
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael J. Kosma
Michael J. Kosma Sherman & Howard675 Fifteenth Street, Suite 2300Denver, CO 80202United States| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical substances being preparations for preserving foodstuffs; chemical preparations for scientific use other than for medical or veterinary use; chemical products being preparations for scientific analyses in laboratories other than for medical or veterinary use; chemical reagents other than for medical or veterinary use; biological preparations for use in science and industry other than for medical or veterinary use; biological tissue cultures other than for medical or veterinary purposes; bacteriological preparations being biological preparations for use in science and industry and other than for medical or veterinary use; bacterial preparations being biological preparations for use in science and industry and other than for medical or veterinary use; bacteriological preparations being biological preparations for use in science and industry for acetification; vitamins for the food industry; vitamins for use in the manufacture of food supplements; vitamins for use in the manufacturing pharmaceutical products; vitamins for use in the manufacturing cosmetics; antioxidants used during manufacturing operations; antioxidants for use in the manufacture of cosmetics; antioxidants for use in the manufacture of food supplements; antioxidants for use in the manufacture of pharmaceutical products; enzyme preparations for industrial use; enzyme preparations for the food industry; enzymes for the food industry | ACTIVE | — |
| 005 | Pharmaceutical preparations for the prevention and treatment of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders; pharmaceutical products being preparations for the prevention and treatment of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders; chemical-pharmaceutical preparations for the prevention and treatment of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders; chemical preparations for medical use for the prevention and treatment of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders; chemical preparations for pharmaceutical use for the prevention and treatment of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders; biological preparations for medical use for the prevention and treatment of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders; biological preparations for veterinary use for the prevention and treatment of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders; vitamin preparations; biological tissue cultures for medical use; biological tissue cultures for veterinary use; cultures of microorganisms for medical or veterinary use; preparations being cultures of microorganisms for medical and veterinary use; bacterial culture preparations for medical or veterinary use; bacteriological culture preparations for medical or veterinary use; diagnostic preparations in the nature of biomarking reagents for medical use; diagnostic preparations for medical use; diagnostic preparations for veterinary use; enzyme food supplements; enzyme preparations for medical use; enzyme preparations for veterinary use; enzymes for medical use; enzymes for veterinary use; immunostimulants; medicinal drinks; medicines for human use for the prevention and treatment of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders, remedies being medications for the prevention and treatment of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders for human use; medicines for veterinary use for the prevention and treatment of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders, remedies being medicines for veterinary use for the prevention and treatment of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders; nutraceutical preparations for therapeutic or medical use for the prevention and treatment of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders; nutritive substances being nutritional supplements for microorganisms; nutritional supplements; opotherapy products being medicinal preparations for the prevention and treatment of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders; protein food supplements; protein supplements for animals; stem cells for medical use; stem cells for veterinary use; preparations of trace elements for human and animal consumption being nutritional supplements | ACTIVE | — |
| 009 | Apparatus for fermentation for laboratory use; chemistry apparatus and instruments, namely, fermentation apparatus for laboratory use for producing bioactive compounds, laboratory robots with artificial intelligence, laboratory robots with automated analysis pipelines, research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids, lockable petri dishes used in laboratory research, diagnostic apparatus for the detection of pathogens for laboratory or research use, laboratory organ-on-chip manufacturing equipment, laboratory 3D cell culture manufacturing equipment; downloadable computer software applications for calculations made for scientific analysis of chemical reactions, downloadable computer software applications for scientific analysis of chemical and biological reactions and downloadable computer software applications for consent management; diagnostic apparatus not for medical use for detection of pathogens for use in laboratory or research use ; DNA chips; laboratory trays | ACTIVE | — |
| 010 | Medical apparatus and instruments for use in preventing and treating cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders; diagnostic apparatus for medical use for analysis and detection of cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease, genetic disorders; cancer, inflammatory disease, immune system disease, cardiovascular disease, neurological and intestinal disease; genetic disorders testing apparatus for medical use; blood testing apparatus; body composition monitors; body fat monitors; physical rehabilitation apparatus for medical use; surgical implants comprised of artificial materials; DNA and RNA testing apparatus for medical use; apparatus for the regeneration of stem cells for medical use | ACTIVE | — |
| 042 | Scientific research; scientific research services for medical purposes; scientific laboratory services; Software as a Service (SaaS) services featuring software for calculations made for scientific analysis of chemical reactions; computer Platform as a Service (PaaS) services featuring software for calculations made for scientific analysis of chemical reactions; medical and scientific research in bacteriology; biological research; chemical analysis; chemical research; chemistry services, namely, chemical analysis and research for others; medical and scientific research, namely, conducting clinical trials for others | ACTIVE | — |
| 044 | Medical analysis services provided by medical laboratories for diagnostic and therapeutic purposes being the treatment of persons and animals; medical screening; human tissue bank services; telemedicine services | ACTIVE | — |
| 045 | Intellectual property licensing | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 13, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 4, 2025 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Apr 4, 2025 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Feb 5, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 5, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 5, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 20, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 20, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 31, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 18, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 17, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 17, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 17, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 5, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 22, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 22, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 22, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 17, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 17, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 6, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 1, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 3, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 2, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 2, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 27, 2023 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| May 24, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 2, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 2, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 13, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 12, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 6, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 16, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 12, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 11, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |